Hematological Disorders Market Landscape | Delveinsight
Wearable Devices: Weighing the Potential Benefits and Pitfalls of the Innovative Wearable Products
recent-pharma-news-updates-for-hebabiz-pfizer-astrazeneca-bms-masimo
AstraZeneca’s Ultomiris; HebaBi...

AstraZeneca's Newly Occupied Alexion Hits Rock Bottom After Ultomiris (Ravulizumab) Fails to Show Efficacy ...

fecal-incontinence-market
Fecal Incontinence Therapeutics Marke...

Fecal Incontinence (FI) is a condition in which individuals lose the control of bowel movements leading to ...

Latest-pharma-happenings-for-rallybio-sanofi-eureka-lilly-unity-biotechnology
Unity’s advanced vascular eye d...

UNITY Biotechnology declares positive data from phase 1 clinical trial of UBX1325 in Advanced Vascular Eye ...

Benefits-advantage-Disadvantages-pros-and-cons-of-wearable-health-devices-technologies
Wearable Devices: Weighing the Potential Benefits and Pitfalls of the Innovative Wearable Products

Wearables are electronic devices that are worn on the body part to track, analyze and transmit real-time personal data of the health or workout. The wearables come in different forms and sizes and...


recent-pharma-biotech-news-updates-for-sanofi-gsk-apellis-innocare-landos
InnoCare’s Trial In China; Sanofi/GSK COVID-19 Vaccine; Apellis’s Empaveli for PNH; LianBio...

InnoCare Receives Go-ahead for Clinical Trial of TYK2 Inhibitor ICP-332 in ChinaInnoCare, a biopharma firm developing novel therapies for the treatment of cancer and autoimmune diseases, today...


COVID-19-Vaccines-Hemophilia-B-uniQure-Gene-Therapy-J-J-Covid-Vaccine-Covaxin
Ocugen-Bharat Biotech’s Covaxin Against B.1.617 Corona Variant; uniQure Shares; J&J Covid V...

Ocugen-Bharat Biotech’s Covaxin Shows Efficacy Against B.1.617 VariantWith the COVID-19 cases exponentially increasing, there is a worrisome climate all over the world. Physicians, doctors, re...


recent-pharma-biotech-lifescience-healthcare-news-updates-for-vertex-virta-kalvista-ovid-crispr-therapeutics
Vertex leads in CRISPR Therapeutics deal; Update for Phase 2 clinical trial of KVD824; Ovid dumps...

Vertex leads in CRISPR Therapeutics partnership with USD 900 Million upfrontVertex has boosted a deal with CRISPR Therapeutics to USD 900 million upfront as the companies compete against blueb...


recent-pharma-biotech-news-updates-for-cidara-jj-supernus-rain
Cidara Therapeutics and J&J’s USD 780M Deal; FDA’s Approval to Supernus’s ADHD drug; Rain Th...

Cidara Therapeutics Inks USD 780M Deal with J&JThe share price of Cidara observed a sudden jump after the news of the collaboration of the company with J&J came. Cidara Therapeutics ha...


chimeric-antigen-receptor-therapies-in-blood-cancers
A New Addition to Existing Chimeric Antigen Receptor Therapies –Potential for a Game Changer in B...

Chimeric Antigen Receptor (CAR) Therapies have changed the treatment paradigm of hematological malignancies to a vast extent. These personalized therapies have not only evolved as a game-changer i...


Chronic Obstructive Pulmonary Disease Market
Chronic Obstructive Pulmo...

According to WHO, Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death g.....

Myelodysplastic Syndrome (MDS) Market Analysis
Myelodysplastic Syndrome ...

Well, MDS being one of the rare blood cancers, has been into the limelight of researchers since a de.....

Prostate Cancer Market
Prostate Cancer...

Prostate Cancer is the second most common malignancy in men worldwide, after lung cancer. Most Prost.....

Editor's Pick
Healthcare Data Breach: What it Means for Companies and the Consumer?

Data and analytics today are playing a major role in the organization’s growth. Stakeho...

Onychomycosis Therapy Market Set to Balloon Up as Emerging Novel Therapies Co...

Onychomycosis is the most commonly prevalent nail infection in adults. It is a fungal i...

Angelman syndrome Pipeline: Unmet needs call for a robust pipeline

The necessity of a robust Angelman syndrome pipeline is indispensable at the current mo...

The New Buzz of Transcranial Stimulation Devices in the Neurological Disorder...

Neurological disorders are one of the major causes of death and disability across the g...

Leading Autoimmune Diseases to Undergo Robust Improvement in Treatment by Maj...

As per the American Autoimmune Related Diseases Association (AARDA), nearly 50 million ...